We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Expose your clinical thinking.
- Abstract
The article discusses the controversy surrounding the disclosure of "clinical trials." Recent juvenile use of GlaxoSmithKline's Paxil should have kept the topic in news. The momentum is gathering behind a call for an international registry of clinical trials. The major argument against such a registry is that to disclose a clinical trial is to give valuable commercial information to the company's competitors. However, it is not always smart to keep quiet about clinical trials, especially for young companies. By exposing a planned clinical approach to the widest possible scrutiny, companies may receive a good deal of feedback from clinicians.
- Subjects
CLINICAL trials; MEDICAL record access control; MEDICAL research; DISCLOSURE; MEDICAL personnel; ECONOMIC competition; DEBATE
- Publication
Nature Biotechnology, 2004, Vol 22, Issue 8, p927
- ISSN
1087-0156
- Publication type
Editorial
- DOI
10.1038/nbt0804-927b